HOME >> BIOLOGY >> NEWS
Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds

ANN ARBOR, Mich. -- Women diagnosed with breast cancer who carry a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments to reduce their risk of cancer returning.

Those are the findings of a 10-year study led by researchers at the University of Michigan Comprehensive Cancer Center. The study authors found that women with the genetic mutation who had their ovaries removed or took the anti-estrogen drug tamoxifen had lower rates of breast cancer recurrence or new breast cancers in the other breast.

Women who carry a mutation on the BRCA1 or BRCA2 gene are at an increased risk of breast cancer compared to women without the mutation. And once diagnosed with breast cancer, they face a higher rate of a second tumor occurring. Because of this, questions remain about whether these women should undergo breast-conserving surgery instead of mastectomy, which removes the entire breast.

In this study, published in the June 1 issue of the Journal of Clinical Oncology, researchers from 11 sites in the United States, Canada and Israel looked at 160 women with early breast cancer and the BRCA1 or BRCA2 gene mutations. The women were treated with lumpectomy, surgery to remove only the tumor, followed by radiation therapy. These women were compared to 445 similar women who were treated for breast cancer but did not carry the genetic mutations.

After 15 years, both groups of women had similar rates of the tumor reoccurring in the same breast. But among the women with the BRCA1 or BRCA2 mutations, those who were further treated by having their ovaries removed, a procedure called oophorectomy, were less likely to have a recurrence. Similarly, tamoxifen dropped the risk of same-breast recurrence for the mutation carriers by 58 percent.

Women with the genetic mutations had a significantly greater risk of developing breast cancer in the opposite breast than did the control group. After 15 years, 45 percent of
'"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
6-Jun-2006


Page: 1 2 3

Related biology news :

1. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Is bigger better? Breast surgery linked to boost in self-esteem and sexuality
4. Microsurgery and Super Glue show how antennae aid moth navigation
5. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
6. Technology helps predict outcome of pediatric heart surgery
7. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
8. OHSU eye doctor says laser surgery safer than contacts
9. Treatment disconnect in kidney cancer: Rising mortality despite more small tumors, more surgery
10. Fitness level affects bariatric surgery outcomes
11. U of MN uses robotic surgery techniques in cardiac cell therapy research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2020)... ... February 04, 2020 , ... Crystal ... the company a second patent related to proprietary liquid crystal technology for rapid ... patent from the USPTO issued on December 3, 2019. Together, these patents protect ...
(Date:1/29/2020)... ... 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the recognized ... a record earnings year for 2019. With final numbers to be released to ... increase in revenue and a thirty percent increase in gross profit, and more ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today ... tech entrepreneur, and former senior management consultant at McKinsey & Company who holds ... alternative investment firm. , “Chris Thorne has exceptional business acumen with a ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal ... cosmetic surgery industry at two recent North American investor forums specializing in medical ... Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 in New York ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies ... Genome editing. The partners have agreed to co-develop and market a portfolio of ... and pre-clinical programs. Over the longer-term, the parties aim to develop a COBO ...
(Date:1/10/2020)... (PRWEB) , ... January 09, 2020 , ... ... and expert services, today announced the acquisition of Cunesoft, a move that expands ... the business objectives of life sciences companies. , Based in Munich, Germany, Cunesoft ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... care helps couples and individuals grow their family, has announced that five of ... by Castle Connolly. Since 1991, the renowned publishing company Castle Connolly ...
Breaking Biology Technology:
Cached News: